/term/bs-payables-and-accrued-expenses/LSE:LLAI LungLife AI (LSE:LLAI) Accounts Payable & Accrued Expense f
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

LungLife AI (LSE:LLAI) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.

LungLife AI (LSE:LLAI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Comparable Companies
LSE:PRM LSE:AGL LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI LSE:DXRX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT
Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
Website
https://www.lunglifeai.com
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.